Abstract
Mycophenolic acid (MPA), ib qho active metabolite ntawm mycophenolate mofetil (MMF), tau tshwm sim los ua ib tug pivotal immunosuppressant nyob rau hauv lub raum kev kho mob. Kab lus no delves rau hauv lub luag haujlwm ntawm MPA hauv kev txo qis kev hloov pauv lub raum tsis lees paub, tshawb nrhiav nws cov txheej txheem ntawm kev ua, kev kho mob ua tau zoo, thiab qhov tseem ceeb ntawm kev saib xyuas cov tshuaj pharmacokinetic rau kev noj tshuaj ib leeg. Tsis tas li ntawd, peb tshuaj xyuas qhov kev sib raug zoo ntawm MPA raug thiab qhov kev pheej hmoo ntawm kev tsis lees paub txog kev toxicity, qhia txog qhov tsim nyog rau cov tswv yim kho mob kom ua kom cov neeg mob tau txais txiaj ntsig zoo.
Taw qhia
Kev hloov hauv lub raum tseem yog tus qauv kub rau kev kho mob raum raum kawg, uas tuaj yeem txhim kho lub neej zoo thiab muaj sia nyob ntawm cov neeg mob. Txawm li cas los xij, kev tsis lees txais kev hloov pauv tseem yog qhov nyuaj thiab yuav tsum tau siv cov tshuaj tiv thaiv kab mob muaj zog. Mycophenolic acid (MPA), daim ntawv nquag ntawm mycophenolate mofetil (MMF), tau dhau los ua ib qho tseem ceeb ntawm cov tshuaj tiv thaiv kab mob niaj hnub no vim nws lub peev xwm tshwj xeeb los inhibit lymphocyte proliferation.
MPA feem ntau ua haujlwm los ntawm inhibiting inosine mononucleotide dehydrogenase (IMPDH), ib qho enzyme xav tau rau lymphocyte DNA synthesis. Los ntawm inhibiting IMPDH, MPA tuaj yeem txo cov lymphocyte proliferation, yog li inhibiting lub cev tiv thaiv kab mob thiab txo qhov kev pheej hmoo ntawm kev hloov pauv. Tsis tas li ntawd, MPA kuj muaj qee yam tshuaj tiv thaiv kab mob, uas tuaj yeem txo qhov kev mob tshwm sim tom qab hloov pauv.
Hauv kev siv tshuaj tiv thaiv kab mob tom qab hloov lub raum, MPA feem ntau siv nrog rau lwm cov tshuaj tiv thaiv kab mob, xws li calcineurin inhibitors (xws li cyclosporine A lossis tacrolimus) thiab glucocorticoids. Qhov kev sib xyaw ua ke no tuaj yeem cuam tshuam kev tiv thaiv kab mob, txo qhov kev pheej hmoo ntawm kev hloov pauv, thiab txhim kho cov neeg mob ciaj sia thiab lub neej zoo.
Mechanism ntawm Action
MPA yog ib qho kev xaiv, tsis sib tw inhibitor ntawm inosine monophosphate dehydrogenase (IMPDH), ib qho enzyme tseem ceeb rau de novo synthesis ntawm guanine nucleotides. Los ntawm inhibiting IMPDH, MPA depletes guanine nucleotides (GMP thiab GTP) hauv lymphocytes, cuam tshuam DNA synthesis thiab ntes lymphocyte proliferation. Tshwj xeeb, MPA nthuav tawm qhov muaj zog inhibitory nyhuv ntawm hom II IMPDH isoform, uas dhau los ua qhov tseem ceeb ntawm kev ua kom lymphocyte. Qhov kev xaiv no inhibition ntawm lymphocyte proliferation, ua ke nrog nws cov nyhuv me me ntawm cov hlwb uas tsis yog lymphoid, pab txhawb rau MPA cov txiaj ntsig thiab kev nyab xeeb profile.
Tsis tas li ntawd, MPA siv cov tshuaj tiv thaiv kab mob ntxiv los ntawm kev hloov pauv cell adhesion molecules, inhibiting glycoprotein synthesis, thiab inducing T-cell apoptosis. Cov txheej txheem ntau yam no pab txhawb rau MPA lub luag haujlwm hauv kev tiv thaiv kev tsis lees paub allograft.
Clinical Efficiency
MPA qhov kev kho mob zoo nyob rau hauv cov neeg mob lub raum pauv tau zoo txuas nrog nws cov tshuaj pharmacokinetic, ntsuas raws li thaj chaw nyob rau hauv lub sijhawm nkhaus (AUC). MPA AUC qhov zoo tshaj plaws tau cuam tshuam nrog kev pheej hmoo siab ntawm biopsy-pom pov thawj mob hnyav, thaum raug ntau dhau tuaj yeem ua rau muaj kev phom sij thiab kis kab mob. Yog li ntawd, kev ua tiav thiab tswj xyuas qhov kev pom zoo MPA AUC yog qhov tseem ceeb rau kev ntsuas qhov kev pheej hmoo ntawm kev tsis lees paub thiab tshuaj lom.
|
|
|
Pharmacokinetic Monitoring
Muab MPA qhov dav ntawm qhov sib txawv ntawm cov tshuaj pharmacokinetic sib txawv, kev tshuaj xyuas tshuaj kho mob (TDM) tau tshwm sim los ua ib qho cuab yeej muaj txiaj ntsig rau tus kheej rau kev tiv thaiv kab mob tiv thaiv kab mob. TDM tso cai rau kev hloov ntawm MMF koob tshuaj raws li MPA trough concentrations (MPA-C0), optimizing immunosuppression thaum txo toxicity.
Cov kev tshawb fawb tau pom tias MPA-C0 qib tuaj yeem kwv yees qhov kev pheej hmoo ntawm kev tsis lees paub thiab tshuaj lom. Piv txwv li, MPA-C0 ntawm 1.55 mg / L tau raug txheeb xyuas tias yog qhov kev txiav tawm zoo tshaj plaws rau kev kwv yees kev tsis lees paub, nrog rau qhov rhiab heev ntawm 69.2% thiab qhov tshwj xeeb ntawm 65.6%. Ib yam li ntawd, MPA-C0 ntawm 2.50 mg / L tau raug pom zoo raws li qhov pib rau kev kwv yees toxicity, nthuav tawm qhov rhiab heev ntawm 67.7% thiab qhov tshwj xeeb ntawm 72.9%.
Cov tswv yim noj tshuaj rau tus kheej
Cov tswv yim txhaj tshuaj rau tus kheej raws li MPA raug pom los txhim kho cov txiaj ntsig kho mob. Cov xwm txheej xws li lub sijhawm tom qab phais, tag nrho cov bilirubin, thiab cov tshuaj sib xyaw ua ke tuaj yeem cuam tshuam rau MPA pharmacokinetics. Kev siv cov qauv nonlinear sib xyaw ua ke (piv txwv li, NONMEM) tau ua kom yooj yim rau kev txhim kho cov pej xeem cov qauv tshuaj pharmacokinetic, ua rau kev kwv yees ntawm tus neeg mob cov lus teb thiab kev ua kom zoo ntawm kev siv tshuaj.
Ntxiv mus, lub enterohepatic ncig (EHC) ntawm MPA pab txhawb rau nws complex pharmacokinetics. MPA yog metabolized rau mycophenolic acid glucuronide (MPAG), uas tau tawm hauv cov kua tsib thiab tom qab ntawd rov nqus hauv plab, ua rau muaj qhov sib txawv ntawm MPA. Kev nkag siab thiab kev suav nyiaj rau qhov tshwm sim no yog qhov tseem ceeb rau kev hloov kho kom raug.
Cov teebmeem tsis zoo thiab toxicity
Txawm hais tias nws ua tau zoo, MPA txoj kev kho tsis yog tsis muaj kev cuam tshuam tsis zoo. Cov kev phiv tshwm sim feem ntau suav nrog kev cuam tshuam ntawm plab hnyuv, anemia, leukopia, thiab kis kab mob. Cov teebmeem tsis zoo no feem ntau yog nyob ntawm koob tshuaj thiab tuaj yeem txo tau los ntawm TDM thiab kev hloov tshuaj.
Txawm li cas los xij, MPA's immunosuppressive zog kuj ua rau muaj kev pheej hmoo ntawm kev kis tus kab mob kis tau zoo thiab cov kab mob malignancies. Kev saib xyuas mus sij hawm ntev thiab kev tiv thaiv kom zoo yog qhov tseem ceeb los txo cov kev pheej hmoo no.
Kev taw qhia yav tom ntej
Kev tshawb fawb txuas ntxiv mus tshawb nrhiav cov txheej txheem tshiab los txhim kho MPA txoj kev ua tau zoo thiab kev nyab xeeb. Piv txwv li, kev txhim kho ntawm kev nthuav tawm cov qauv tsim tawm thiab cov tshuab xa tawm tshiab tuaj yeem txhim kho MPA cov tshuaj pharmacokinetic profile thiab txo cov koob tshuaj ntau zaus. Tsis tas li ntawd, kev koom ua ke ntawm cov tshuaj pharmacogenomics rau hauv TDM tuav cov lus cog tseg rau kev kho tus kheej ntxiv rau kev tiv thaiv kab mob, ua kom muaj txiaj ntsig zoo thaum txo cov tshuaj lom.
Xaus
Mycophenolic acid, active metabolite ntawm mycophenolate mofetil, plays lub luag hauj lwm tseem ceeb hauv kev tiv thaiv kev hloov hauv lub raum. Nws cov txheej txheem tshwj xeeb ntawm kev ua haujlwm, tsom mus rau lymphocyte proliferation, ua ke nrog nws qhov kev nyab xeeb zoo, tau ua MPA lub hauv paus ntawm cov txheej txheem tiv thaiv kab mob niaj hnub no. TDM-kev coj noj coj ua ntawm tus kheej cov tswv yim noj tshuaj, raws li MPA pharmacokinetics, tau ua kom cov neeg mob tau txais txiaj ntsig zoo dua los ntawm kev ntsuas qhov kev pheej hmoo ntawm kev tsis lees paub thiab toxicity.
Feem ntau, MPA, ua ib feem tseem ceeb ntawm kev tiv thaiv kab mob tom qab hloov lub raum, ua lub luag haujlwm tseem ceeb hauv kev txhim kho cov neeg mob ciaj sia thiab lub neej zoo. Txawm li cas los xij, nws txoj kev siv kuj yuav tsum tau ua tib zoo saib xyuas thiab tswj cov kev mob tshwm sim. Nrog rau kev txhim kho txuas ntxiv ntawm kev kho mob thev naus laus zis, nws ntseeg tias ntau thiab ntau dua cov tshuaj tiv thaiv kab mob yuav raug tsim nyob rau yav tom ntej kom coj tau zoo dua kev kho mob thiab kev ua neej zoo rau cov neeg mob hloov lub raum.
Cov ntaub ntawv
Li Weimo. Kev tshawb fawb soj ntsuam ntawm kev sib raug zoo ntawm trough concentration ntawm mycophenolic acid thiab acute rejection thiab tshuaj toxicity nyob rau hauv lub raum hloov neeg mob. Southern Medical University.
Jiao Zheng. Tsev Kho Mob Huashan koom nrog Fudan University. Population pharmacokinetics txoj kev tshawb fawb thiab kev siv tshuaj ib leeg ntawm mycophenolic acid hauv cov neeg mob raum hloov pauv [D].
Cov kws tshaj lij pom zoo rau kev siv cov tshuaj mycophenolic acid hauv daim siab thiab lub raum hloov cov neeg tau txais kev pab hauv Suav teb (2023 tsab). Shanghai Pharmaceuticals.
[Cov Lus Qhia]: Lub Hom Phiaj: Cov txiaj ntsig kho mob ntawm mycophenolate mofetil (MMF) muaj feem cuam tshuam nrog thaj tsam hauv qab lub sijhawm nkhaus (AUC) ntawm nws cov metabolite mycophenolic acid (MPA).
Southern Medical University. Mycophenolate mofetil (MMF) yog ib qho kev siv tshuaj tiv thaiv kab mob tom qab hloov khoom nruab nrog cev ...
Kev siv tshuaj kho tus kheej ntawm cov tshuaj mycophenolic acid tom qab hloov lub raum. Clinical rational siv tshuaj.
Suav Journal of Drug Application and Monitoring. Xyoo 2013 06.
Suav Journal of Clinical Pharmacology. Xyoo 2023 11.